Search research articles
Contact Us
Filters
Showing results (281-290 of 303) with videos related to
Page
of 31
Sort By:
The Journal of Rheumatology
|
October 16, 2020
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus
Daniela Dominguez, Sylvia Kamphuis, Joseph Beyene, et al.
Blood
|
December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
Judith E Karp, Karen Flatten, Eric J Feldman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience
Alexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Transplantation and Cellular Therapy
|
February 14, 2022
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis
Tania Jain, Hua-Ling Tsai, Amy E DeZern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Acute myeloid leukemia, version 2.2013
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Blood
|
October 16, 2014
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, et al.
Blood
|
January 5, 2017
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide
Christopher G Kanakry, Javier Bolaños-Meade, Yvette L Kasamon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael W Deininger, Neil P Shah, Jessica K Altman, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 303) with videos related to
Sort By:
Page
of 31
The Journal of Rheumatology
|
October 16, 2020
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus
Daniela Dominguez, Sylvia Kamphuis, Joseph Beyene, et al.
Blood
|
December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
Judith E Karp, Karen Flatten, Eric J Feldman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience
Alexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Transplantation and Cellular Therapy
|
February 14, 2022
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis
Tania Jain, Hua-Ling Tsai, Amy E DeZern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Acute myeloid leukemia, version 2.2013
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Blood
|
October 16, 2014
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, et al.
Blood
|
January 5, 2017
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide
Christopher G Kanakry, Javier Bolaños-Meade, Yvette L Kasamon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael W Deininger, Neil P Shah, Jessica K Altman, et al.
Page
of 31